The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
those things we can also what we do nowadays is we try to relate those biofread biomarkers with the neural Imaging features that we see in people to try to correlate whether there is if you have high level of parasite problems do you have more weight manual disease and things like that we try to relate what we see in the blood and CSF to what we see in the brain and obviously we look at cognition whether
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we know that people that do have smallest smallest of disease they are very high levels of soluble form of this cell addition molecules that can detect in biofluids so that's already a feature